Next generation Sequencing Market - Forecasts from 2018 to 2023
Next generation sequencing market is projected to expand at a CAGR of 20.21%, to grow from US$4.374 billion in 2017 to US$13.198 billion by 2023. The global demand for next-generation sequencing (NGS) products and services is highly driven by an increase in the application of NGS, technological advancement in NGS technology, increase in genome mapping programs, and surge in collaborations and partnerships resulting in high investments in R&D in NGS technology. The efficient replacement of traditional technologies (microarrays), cost efficiency, speed and accuracy of technology along with the rise in the application in drug discovery will aid to the global next-generation sequencing demand growth over next five years. However, lack of skilled professionals, interpretation of complex data, and legal and ethical issues are expected to hinder the NGS market growth.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the pressure sensors value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the market.
Major industry players profiled as part of the report are Roche Holding AG, Agilent Technologies, Thermo Fisher Scientific, Beijing Genomics Institute, GATC Biotech AG, and Pacific Biosciences of California, Inc. among others.
SEGMENTATION
The next generation sequencing market has been analyzed through following segments:
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the pressure sensors value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the market.
Major industry players profiled as part of the report are Roche Holding AG, Agilent Technologies, Thermo Fisher Scientific, Beijing Genomics Institute, GATC Biotech AG, and Pacific Biosciences of California, Inc. among others.
SEGMENTATION
The next generation sequencing market has been analyzed through following segments:
- By Product and Services
- Sequencing Systems
- Consumables
- Software
- Sequencing Services and Analysis
- By Technology
- Sequencing by Synthesis
- ION Torrent Sequencing
- Nanopore Sequencing
- Others
- By Application
- Agriculture and Animal Research
- Biomarker Discovery
- Drug Discovery
- Diagnostics
- Precision Medicine
- By Geography
- North America
- USA
- Canada
- Mexico
- Others
- South America
- Brazil
- Argentina
- Others
- Europe
- Germany
- France
- United Kingdom
- Spain
- Others
- Middle East and Africa
- UAE
- Israel
- South Africa
- Others
- Asia Pacific
- China
- Japan
- India
- South Korea
- Others
1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. NEXT GENERATION SEQUENCING MARKET BY PRODUCTS AND SERVICES
5.1. Sequencing Systems
5.2. Consumables
5.3. Software
5.4. Sequencing Services and Analysis
6. NEXT GENERATION SEQUENCING MARKET BY TECHNOLOGY
6.1. Sequencing by Synthesis
6.2. ION Torrent Sequencing
6.3. Nanopore Sequencing
6.4. Others
7. NEXT GENERATION SEQUENCING MARKET BY APPLICATION
7.1. Agriculture and Animal Research
7.2. Biomarker Discovery
7.3. Drug Discovery
7.4. Diagnostics
7.5. Precision Medicine
8. NEXT GENERATION SEQUENCING MARKET BY GEOGRAPHY
8.1. North America
8.1.1. USA
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. United Kingdom
8.3.4. Spain
8.3.5. Others
8.4. Middle East and Africa
8.4.1. UAE
8.4.2. Israel
8.4.3. South Africa
8.4.4. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Investment Analysis
9.3. Recent Deals
9.4. Strategies of Key Players
10. COMPANY PROFILES
10.1. Roche Holding AG
10.1.1. Company Overview
10.1.2. Financials
10.1.3. Products and Services
10.1.4. Recent Developments
10.2. Agilent Technologies
10.2.1. Company Overview
10.2.2. Financials
10.2.3. Products and Services
10.2.4. Recent Developments
10.3. Illumina, Inc.
10.3.1. Company Overview
10.3.2. Financials
10.3.3. Products and Services
10.3.4. Recent Developments
10.4. Thermo Fisher Scientific
10.4.1. Company Overview
10.4.2. Financials
10.4.3. Products and Services
10.4.4. Recent Developments
10.5. Macrogen, Inc.
10.5.1. Company Overview
10.5.2. Financials
10.5.3. Products and Services
10.5.4. Recent Developments
10.6. Beijing Genomics Institute
10.6.1. Company Overview
10.6.2. Financials
10.6.3. Products and Services
10.6.4. Recent Developments
10.7. Qiagen
10.7.1. Company Overview
10.7.2. Financials
10.7.3. Products and Services
10.7.4. Recent Developments
10.8. DNASTAR
10.8.1. Company Overview
10.8.2. Financials
10.8.3. Products and Services
10.8.4. Recent Developments
10.9. GATC Biotech AG
10.9.1. Company Overview
10.9.2. Financials
10.9.3. Products and Services
10.9.4. Recent Developments
10.10. Pacific Biosciences of California, Inc.
10.10.1. Company Overview
10.10.2. Financials
10.10.3. Products and Services
10.10.4. Recent Developments
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. NEXT GENERATION SEQUENCING MARKET BY PRODUCTS AND SERVICES
5.1. Sequencing Systems
5.2. Consumables
5.3. Software
5.4. Sequencing Services and Analysis
6. NEXT GENERATION SEQUENCING MARKET BY TECHNOLOGY
6.1. Sequencing by Synthesis
6.2. ION Torrent Sequencing
6.3. Nanopore Sequencing
6.4. Others
7. NEXT GENERATION SEQUENCING MARKET BY APPLICATION
7.1. Agriculture and Animal Research
7.2. Biomarker Discovery
7.3. Drug Discovery
7.4. Diagnostics
7.5. Precision Medicine
8. NEXT GENERATION SEQUENCING MARKET BY GEOGRAPHY
8.1. North America
8.1.1. USA
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. United Kingdom
8.3.4. Spain
8.3.5. Others
8.4. Middle East and Africa
8.4.1. UAE
8.4.2. Israel
8.4.3. South Africa
8.4.4. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Investment Analysis
9.3. Recent Deals
9.4. Strategies of Key Players
10. COMPANY PROFILES
10.1. Roche Holding AG
10.1.1. Company Overview
10.1.2. Financials
10.1.3. Products and Services
10.1.4. Recent Developments
10.2. Agilent Technologies
10.2.1. Company Overview
10.2.2. Financials
10.2.3. Products and Services
10.2.4. Recent Developments
10.3. Illumina, Inc.
10.3.1. Company Overview
10.3.2. Financials
10.3.3. Products and Services
10.3.4. Recent Developments
10.4. Thermo Fisher Scientific
10.4.1. Company Overview
10.4.2. Financials
10.4.3. Products and Services
10.4.4. Recent Developments
10.5. Macrogen, Inc.
10.5.1. Company Overview
10.5.2. Financials
10.5.3. Products and Services
10.5.4. Recent Developments
10.6. Beijing Genomics Institute
10.6.1. Company Overview
10.6.2. Financials
10.6.3. Products and Services
10.6.4. Recent Developments
10.7. Qiagen
10.7.1. Company Overview
10.7.2. Financials
10.7.3. Products and Services
10.7.4. Recent Developments
10.8. DNASTAR
10.8.1. Company Overview
10.8.2. Financials
10.8.3. Products and Services
10.8.4. Recent Developments
10.9. GATC Biotech AG
10.9.1. Company Overview
10.9.2. Financials
10.9.3. Products and Services
10.9.4. Recent Developments
10.10. Pacific Biosciences of California, Inc.
10.10.1. Company Overview
10.10.2. Financials
10.10.3. Products and Services
10.10.4. Recent Developments
